You just read:

New Analysis from Landmark CREDENCE Study Shows the Efficacy and Safety Profiles of INVOKANA® (canagliflozin) are Consistent Across Various Levels of Kidney Function

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Nov 09, 2019, 16:30 ET